GL1X · GenesisL1 explorer

MolNFT v1 · #129320 · protein

Structure of cathepsin B1 from schistosoma mansoni in complex with WRR391 inhibitor

5OGQ · Cathepsin B-like peptidase (C01 family): “Structure of cathepsin B1 from schistosoma mansoni in complex with WRR391 inhibitor”. X-ray diffraction, 1 ligand (9U8), 8 pockets (best druggability 0.56). MolNFT v1 #129320 on GenesisL1…

PDB
5OGQ
Type
protein
Length
762 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cathepsin B-like peptidase (C01 family)
UniProt
Q8MNY2
Ligands
9U8
Pockets
8 · best druggability 0.56

Structure

x-ray diffraction · 1 distinct chain · 28% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, CCathepsin B-like peptidase (C01 family)protein25428% helix, 21% strandQ8MNY2

Ligands and binding sites

  • 9U8 · ethyl 1-[[(2~{S})-3-(4-hydroxyphenyl)-1-oxidanylidene-1-[[(3~{S})-1-phenyl-5-pyridin-2-ylsulfonyl-pentan-3-yl]amino]propan-2-yl]carbamoyl]piperidine-4-carboxylate · ligand · 3 copies · chains A, B, C
  • ACT · Acetate ion · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13840.560.7434empty
22040.520.7725empty
32030.520.77279U8
42200.520.76309U8
51540.470.7724empty

Interfaces

2 interfaces between chains.

  • B–C · 386 Ų buried · 3 hydrogen bonds · protein-protein
  • A–B · 78 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 18 disulfide, 3 covalent (disulfide, covalent ligand).

Compared structures

  • 5OGQ · Structure of cathepsin B1 from Schistosoma mansoni in complex with WRR391 inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.